- 商品介绍
- 规格参数
- 包装参数
Application
Trandolapril has been used as an angiotensin-converting enzyme (ACE) inhibitor to study its effects on responsiveness of human retinal endothelial cells (HRECs) to vascular endothelial growth factor (VEGF).
Biochem/physiol Actions
Studies have reported that trandolapril inhibits atherosclerosis1 and decreases the occurrence of atrial fibrillation2.
Trandolapril is an ACE inhibitor.
Trandolapril is an ACE inhibitor. Trandolapril differs from other ACE inhibitors in that it has a longer biological half-life and a high degree of lipophilicity.
Features and Benefits
This compound was developed by Abbott. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Preparation Note
Trandolapril is soluble in DMSO at a concentration that is greater than or equal to 20 mg/ml.
| Quality Segment | 100 |
| assay | ≥98% (HPLC) |
| form | powder |
| color | white |
| solubility | DMSO: ≥20 mg/mL |
| originator | Abbott |
| SMILES string | CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2C3CCCCC3C[C@H]2C(O)=O |
| InChI | 1S/C24H34N2O5/c1-3-31-24(30)19(14-13-17-9-5-4-6-10-17)25-16(2)22(27)26-20-12-8-7-11-18(20)15-21(26)23(28)29/h4-6,9-10,16,18-21,25H,3,7-8,11-15H2,1-2H3,(H,28,29)/t16-,18+,19-,20-,21-/m0/s1 |
| InChI key | VXFJYXUZANRPDJ-WTNASJBWSA-N |
| Gene Information | human ... ACE(1636) |
| 长度(mm) | |
| 宽度(mm) | |
| 高度(mm) | |
| 重量(kg) |
-
询价
-
询价
-
¥ 2622.09
-
¥ 1259.40
-
¥ 2013.69
-
¥ 2019.57
-
询价
-
询价
-
询价
-
询价
-
询价
-
询价
-
询价
-
询价
-
询价
-
¥ 954.17
-
¥ 5804.96
-
询价
-
¥ 5990.26
-
询价
微信小程序
7X24小时在线咨询